BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TrialSonar//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TrialSonar · $4503.T readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by TrialSonar. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03505320-pcd@trialsonar.netlify.app
DTSTAMP:20261118T125025Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:ILUSTRO readout (P2) · Astellas Pharma Global Development\, Inc. $
 4503.T
DESCRIPTION:A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
 \n\nPrimary completion date: 2027-06-30 (estimated)\nOriginally planned: 2
 020-04 (+86.9 months)\nPhase 2 · Oncology · Pharmacokinetics of Zolbetux
 imab\, Gastric Cancer\, Gastro-esophageal Junction (GEJ) Cancer\nEnrollmen
 t: 143 · Sites: 21\n\nPrimary completion = last participant's primary-end
 point data collected\; topline results usually follow weeks to months late
 r. Sponsor-reported\, often an estimate. Not investment advice.\n\nhttps:/
 /trialsonar.netlify.app/radar.html?nct=NCT03505320\nhttps://clinicaltrials
 .gov/study/NCT03505320
URL:https://datacutoff.com/radar.html?nct=NCT03505320
CATEGORIES:Oncology,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05970172-pcd@trialsonar.netlify.app
DTSTAMP:20261118T125025Z
DTSTART;VALUE=DATE:20271030
DTEND;VALUE=DATE:20271031
SUMMARY:Roxadustat readout (P3) · Astellas Pharma Global Development\, Inc
 . $4503.T
DESCRIPTION:A Study of Roxadustat to Treat Anemia in Children and Teenagers
  With Chronic Kidney Disease\n\nPrimary completion date: 2027-10-30 (estim
 ated)\nOriginally planned: 2025-11-30 (+23.0 months)\nPhase 3 · Cardio-Me
 t · Chronic Kidney Disease\, Renal Anemia\nEnrollment: 98 · Sites: 47\n\
 nPrimary completion = last participant's primary-endpoint data collected\;
  topline results usually follow weeks to months later. Sponsor-reported\, 
 often an estimate. Not investment advice.\n\nhttps://trialsonar.netlify.ap
 p/radar.html?nct=NCT05970172\nhttps://clinicaltrials.gov/study/NCT05970172
URL:https://datacutoff.com/radar.html?nct=NCT05970172
CATEGORIES:Cardio-Met,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
